Good quality empirical information is key to understanding current developments in the international patent system.

It took 30 years for Chemical Abstracts Service to publish its first million abstracts. CAS indexed more than a million records in 2006 alone, reflecting the accelerated pace of research and discovery around the globe.

On September 19, 2007, the Commissioner of Patents granted to the generic drug company Apotex, Inc. an authorization to manufacture a pharmaceutical product used in the treatment of HIV/AIDS for export to Rwanda.

HØRSHOLM, Denmark - Additional Agreement for Technology Partnership

Summary: LifeCycle Pharma announces US partnership with Sciele Pharma for LCP-FenoChol and also enters into Technology Partnership for MeltDose(R) Technology

PARIS, France - Nautilus Biotech, a leading drug discovery and development company, today announced the signing of a collaboration and license agreement with HanAll Pharmaceutical (KSE, 009420) to develop and commercialize three Nautilus Biotech products in South Korea: Belerofon(R) (Interferon alpha); Vitatropin(R) (human growth hormone); and Eporal(TM) (erythropoietin).

WAYNE, PA., - PharmaStem Therapeutics, Inc. announced today that the United States Patent and Trademark Office has issued a ruling confirming the validity of PharmaStem Therapeutics, Inc.'s pioneering patent about the Isolation and Preservation of Fetal and Neonatal Hematopoietic Stem and Progenitor Cells of the Blood and Methods of Therapeutic Use.

KENILWORTH, New Jersey - Schering-Plough Corporation (NYSE: SGP) announced on december 14, 2006 the signing of definitive licensing agreements with Valeant Pharmaceuticals International (NYSE: VRX) and Metabasis Therapeutics, Inc. (Nasdaq: MBRX) for exclusive worldwide development and commercial rights to pradefovir, an investigational oral antiviral compound currently in Phase II clinical development for the treatment of chronic hepatitis B.